Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)
Preptin; Proinsulin-Like Growth Factor-II
- Product No.CEA707Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range37.0-3,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 12.7pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 441
For more details, please contact local distributors! US$ 630 US$ 2835 US$ 5355 US$ 44100
Specificity
This assay has high sensitivity and excellent specificity for detection of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE).
No significant cross-reactivity or interference between Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and the recovery rates were calculated by comparing the measured value to the expected amount of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 86-97 | 91 |
EDTA plasma(n=5) | 87-96 | 91 |
heparin plasma(n=5) | 91-102 | 96 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 82-101% | 97-104% | 86-96% | 83-104% |
EDTA plasma(n=5) | 94-102% | 99-105% | 78-99% | 80-95% |
heparin plasma(n=5) | 80-104% | 87-102% | 78-90% | 78-101% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Appl Physiol Nutr Metab | Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults PubMed: 25675353 |
Journal of Pediatric Endocrinology and Metabolism | Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection PubMed: 25719300 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
CEA707Hu | ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA707Hu | Multiplex Assay Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |